110 related articles for article (PubMed ID: 23527524)
21. Treatment of resistant disease.
Schiller GJ
Leukemia; 1998 Sep; 12 Suppl 1():S20-4. PubMed ID: 9777890
[TBL] [Abstract][Full Text] [Related]
22. Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy.
Gruber A; Areström I; Albertioni F; Björkholm M; Peterson C; Vitols S
Leuk Lymphoma; 1995 Aug; 18(5-6):435-42. PubMed ID: 8528050
[TBL] [Abstract][Full Text] [Related]
23. Multidrug resistance in haematological malignancies.
Sonneveld P
J Intern Med; 2000 May; 247(5):521-34. PubMed ID: 10809991
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of acute myelogenous leukemia and strategies to overcome multidrug resistance].
Motoji T
Rinsho Ketsueki; 2007 Oct; 48(10):1300-11. PubMed ID: 17933114
[No Abstract] [Full Text] [Related]
25. The priming induction regimen of HAG as a low dose chemotherapy strategy in AML clonal evolution.
Chen A; Yang J; Hu S; Wang QF
Sci China Life Sci; 2015 Dec; 58(12):1302-5. PubMed ID: 26588914
[No Abstract] [Full Text] [Related]
26. Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy.
Boyiadzis M; Redner RL; Raptis A; Hou JZ; Agha M; Foon KA
Ann Hematol; 2011 Jun; 90(6):733-5. PubMed ID: 20857113
[No Abstract] [Full Text] [Related]
27. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
[TBL] [Abstract][Full Text] [Related]
28. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples.
Khamenehfar A; Gandhi MK; Chen Y; Hogge DE; Li PC
Anal Chem; 2016 Jun; 88(11):5680-8. PubMed ID: 27149245
[TBL] [Abstract][Full Text] [Related]
29. Prediction of early death in adults with relapsed or refractory acute myeloid leukemia.
Godwin CD; Othus M; Powell MA; Buckley SA; Estey EH; Walter RB
Leuk Lymphoma; 2016 Oct; 57(10):2421-4. PubMed ID: 26754357
[No Abstract] [Full Text] [Related]
30. Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60).
Kachalaki S; Baradaran B; Majidi J; Yousefi M; Shanehbandi D; Mohammadinejad S; Mansoori B
Biomed Pharmacother; 2015 Oct; 75():100-4. PubMed ID: 26463638
[TBL] [Abstract][Full Text] [Related]
31. Multidrug resistance of acute leukemia and a strategy to overcome it.
Motoji T; Motomura S; Wang YH
Int J Hematol; 2000 Dec; 72(4):418-24. PubMed ID: 11197207
[TBL] [Abstract][Full Text] [Related]
32. The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.
Ascione A; Cianfriglia M; Dupuis ML; Mallano A; Sau A; Pellizzari Tregno F; Pezzola S; Caccuri AM
Cancer Chemother Pharmacol; 2009 Jul; 64(2):419-24. PubMed ID: 19288261
[TBL] [Abstract][Full Text] [Related]
33. The biological significance of the multidrug resistance gene MRP in inversion 16 leukemias.
Kuss BJ; Deeley RG; Cole SP; Willman CL; Kopecky KJ; Wolman SR; Eyre HJ; Callen DF
Leuk Lymphoma; 1996 Feb; 20(5-6):357-64. PubMed ID: 8833390
[TBL] [Abstract][Full Text] [Related]
34. [Multidrug resistance in acute nonlymphoid leukemia].
Michieli M; Geromin A; Damiani D; Michelutti A; Raspadori D; Masotti A; Russo D; Fanin R; Fasola G; Mallardi F
Haematologica; 1991 Jun; 76 Suppl 3():165-8. PubMed ID: 1684342
[No Abstract] [Full Text] [Related]
35. Mutant DNMT3A clone evading chemotherapy and infiltrating central nervous system in a patient with molecularly good-risk acute myeloid leukemia.
Chen YY; Huang CE; Chou HJ; Tsai PS; Lu CH; Chen MF; Lee KD; Chen PT; Lung J; Chen CC
Ann Hematol; 2014 Aug; 93(8):1441-2. PubMed ID: 24337413
[No Abstract] [Full Text] [Related]
36. Coexpression of Multiple ABC-Transporters is Strongly Associated with Treatment Response in Childhood Acute Myeloid Leukemia.
Bartholomae S; Gruhn B; Debatin KM; Zimmermann M; Creutzig U; Reinhardt D; Steinbach D
Pediatr Blood Cancer; 2016 Feb; 63(2):242-7. PubMed ID: 26512967
[TBL] [Abstract][Full Text] [Related]
37. Long-arm deletions in chromosome 6 in acute myelogenous leukemia: update on two cases.
Sundareshan TS; Lakshmi Devi V; Madhumathi DS; Appaji L; Girish MH; Prabhash K; Bapsy PP
Cancer Genet Cytogenet; 2004 Oct; 154(1):93-5. PubMed ID: 15381383
[No Abstract] [Full Text] [Related]
38. [Progress in the treatment of adult acute myeloid leukemia].
Ohno R
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1053-8. PubMed ID: 9239156
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of the multidrug resistance MDR1 gene expression in clinical leukemia with RT-PCR].
Zhang H; Shi G; Wang J
Zhonghua Nei Ke Za Zhi; 1995 Jul; 34(7):463-7. PubMed ID: 8556928
[TBL] [Abstract][Full Text] [Related]
40. The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia.
Deng L; Jiang L; Lin XH; Tseng KF; Liu Y; Zhang X; Dong RH; Lu ZG; Wang XJ
Acta Pharmacol Sin; 2017 Mar; 38(3):382-391. PubMed ID: 28042875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
